13 June 2012 15:16 [Source: ICIS news]
HOUSTON (ICIS)--Gevo will continue to optimise operations at a bio-based isobutanol facility in ?xml:namespace>
Gevo was reacting to a statement by rival Butamax that a
Gevo said that the court instructed it to “maintain the status quo” on the Laverne plant.
“As the judge has not made a decision for or against the preliminary injunction to date, it’s understandable that she wants to make sure Gevo sticks to its current business plan,” said Gevo executive vice president Brett Lund.
“For Gevo, that means we continue to optimise Luverne operating parameters […] and most importantly we sell our renewable isobutanol to Sasol and the US Air Force,”
Butamax had welcomed the court order, saying that it “provides protection for markets of key interest to Butamax.”
Butamax said the order stated that Gevo “shall not deliver, provide, distribute, ship, release, or transfer in any way bio-based isobutanol produced at Gevo’s Luverne facility from recombinant yeast microorganisms to any third party for any use or purpose, except that it may sell its bio-based isobutanol produced at the Luverne facility to Sasol for chemical applications and the US Air Force for jet fuel testing applications”.
Butamax is a joint venture between DuPont and BP.
Check out Doris de Guzman’s Green Chemicals Blog for views on sustainability issues
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections